Briacell Therapeutics (BCTX) PT Lowered to $20 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts BCTX Hot Sheet
Price: $3.19 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 33 | New: 6
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 33 | New: 6
Join SI Premium – FREE
H.C. Wainwright analyst Emily Bodnar lowered the price target on Briacell Therapeutics (NASDAQ: BCTX) to $20.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades Chevron (CVX) to Hold
- Modine Manufacturing (MOD) PT Lowered to $235 at DA Davidson
- Dutch Bros Inc. (BROS) PT Lowered to $55 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
